References
Teramura T, Watanabe T, Higuchi S, et al. Metabolism and pharmacokinetics of barnidipine hydrochloride, a calcium channel blocker, in man following oral administration of its sustained release formulation. Xenobiotica 1997 Feb; 27(2): 203–16
Yoshinaga K, Iimura O, Abe K, et al. Clinical effects of YM730 (mepirodipine hydrochloride) on essential hypertension. Multicenter open trial by monotherapy and concomitant therapy. Pharmacotherapy Ther 1990; 18: 3103–20
Yoshinaga K, Iimura O, Abe K, et al. Clinical evaluation of YM730 (mepirodipine hydrochloride) in the treatment of essential hypertension. A double-blind comparative clinical trial with a sustained-release preparation of nicardipine hydrochloride as a control Igaku no Ayumi 1991; 156: 543–60
Imai Y, Abe K, Nishiyama A, et al. Evaluation of the antihypertensive effect of barnidipine, a dihydropyridine calcium entry blocker, as determined by the ambulatory blood pressure level averaged for 24 h, daytime, and nighttime. Barnidipine Study Group. Am J Hypertens 1997 Dec; 10 (12 Pt 1): 1415–9
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saruta, T. Barnidipine. Drugs 61, 997–998 (2001). https://doi.org/10.2165/00003495-200161070-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-200161070-00009